In line with these findings, gene set enrichment analysis (GSEA) of publicly available microarray data15 revealed that multiple components of IL2-STAT5 signaling and MYC target genes were among the most downregulated gene sets in AML cell lines after R406 treatment (Fig. 1E). Here, IL2 is linked to acute myeloid leukemia.